期刊文献+

shRNA腺病毒介导的JNK1 RNAi抑制U87MG人胶质瘤细胞的增殖 被引量:2

JNK1 Knockdown via Adenovirus-mediated shRNA Inhibited Cell Proliferation in U87MG Gliobalstoma Cells
下载PDF
导出
摘要 目的研究腺病毒介导的shRNA对U87MG人胶质瘤细胞JNK1基因表达的抑制作用,以及对细胞增殖的影响。方法设计合成针对JNK1基因以及无义对照的shRNA序列,通过腺病毒介导shRNA的表达来下调JNK1的表达;Q-PCR和Western blot验证病毒效果;用BrdU掺入的方法来检测细胞的增殖情况。结果限制性酶切及DNA测序结果证实shRNA插入片段完全正确;Q-PCR和Western blot结果表明JNK1的表达与对照组相比明显下降;BrdU掺入结果表明Ad-shJNK1处理组细胞增殖显著降低。结论重组的JNK1shRNA腺病毒构建成功,JNK1的下调明显抑制了细胞的增殖,为深入研究JNK信号通路在神经肿瘤中的作用奠定基础。 Objective To investigate the effects of adenovirus-mediated shRNA targeting c-jun N-terminal kinase 1(JNK1) in U87MG human glioblastoma cells,so as to reveal the relationship between JNK1 and cell proliferation in brain tumor.Methods shRNA sequence against JNK1 and nonsense sense oligonucleotides were designed;after producing recombinant adenovirus,Q-PCR and Western blot were used to test knockdown effect in U87MG cells;BrdU incorporation was used to observe cell proliferation.Results Recombinant vector was confirmed by restriction endonuclease analysis and DNA sequencing;Q-PCR and Western blot results indicated the expression of JNK1 was significantly decreased compared with the other control groups.BrdU incorporation revealed cell proliferation rate was markedly inhibited in JNK1 RNAi group in comparison with control groups.Conclusion Recombinant adenovirus expressing shRNA targeting JNK1 was constructed successfully,and cell proliferation was significantly inhibited after JNK1 knockdown in U87MG cells;it paves the way for further research on JNK pathway involving in development of brain tumor.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第7期767-769,共3页 Cancer Research on Prevention and Treatment
基金 国家科技部基金资助项目(2009ZX09103-733 2009ZX09301-010)
关键词 C-JUN氨基末端激酶 RNA干扰 小发夹RNA 细胞增殖 神经肿瘤 c-jun N-terminal kinase RNA interference shRNA Cell proliferation Brain tumor
  • 相关文献

参考文献1

共引文献122

同被引文献33

  • 1周志龙,步星耀,闫兆月,马春晓,王跃伟,雒建超.脑恶性胶质瘤术后会师化疗同步适形放疗的临床观察[J].肿瘤防治研究,2014,41(4):374-378. 被引量:4
  • 2Zhu CQ, Pintilie M, John T, et al. Understanding prognostic gene expression signatures in lung cancer [J]. Clin Lung Can cer,2009,10(5):331-40.
  • 3Guo W, Giancotti FG. Integrin signalling during tumour pro- gression [J]. Nat Rev Mol Cell Biol,2004,5(10):816-26.
  • 4Bon G,Folgiero V,Bossi G,et al. I.oss of beta4 integrin sub unit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation [J]. Clin Cancer Res,2t)06,12(ll Pt 1) :3280- 7.
  • 5Cruz-Monserrate Z,O'Connor KL. Integrin alpha 6 beta 4 pro motes migration, invasion through Tiaml upregulation, and subsequent Rac activation [J]. Neoplasia,2008,10(5) :408 -17.
  • 6Kitajiri S, Hosaka N, Hiraumi H,et al. Increased expression of integrin beta 4 in papillary thyroid carcinoma with gross lymph node metastasis [J]. Pathol Int,2002,52(7):438-41.
  • 7Ni H, Dydensborg AB, Herring FE, et al. Upregulation of a functional form of the .beta4 integrin subunit in colorecta/canc- ers correlates with c-Myc expression[J]. Oncogene, 2005,24 (45) :6820-9.
  • 8Davis TI.,Cress AE, Dalkin BI., et al. Unique expression pat- tern of the alpha6beta4 integrin and laminin 5 in human prostare carcinoma [J]. Prostate,2001,46(3) 1240-8.
  • 9Yang X, Pursell B, Lu S, et al. Regulation of beta 4-integrin ex- pression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition[J]. J Cell Sci, 2009,122(Pt 44) :2473-80.
  • 10Giancotti FG. Targeting integrin beta4 for cancer and anti-an- giogenic therapy [J]. Trends Pharmacol Sci, 2007, 28 (10) : 506-11.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部